Hikma Pharmaceutical | HIK - Cash And Equivalent

Stock Price
1,285.50
Daily Change
-22.50 -1.72%
Monthly
7.93%
Yearly
-30.17%
Q2 Forecast
1,279.62

Hikma Pharmaceutical reported $236M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Almirall EUR 337.77M 14.83M Dec/2025
argenx SE USD 4.3B 2.21B Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Autolus Therapeutics Ltd USD 104.13M 18.01M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Galapagos EUR 87.87M 23.41M Dec/2025
Genmab DKK 1.72B 46M Dec/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 719M 188M Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Orion EUR 160.9M 63.3M Dec/2025
Recordati EUR 471.46M 129.91M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024